[18F]Fluorodeoxyglucose ([18F]FDG) positron emission tomography and conventional imaging modalities in the diagnosis of diabetic foot osteomyelitis: a meta-analysis

被引:1
|
作者
Jin, Y. [1 ]
Huang, K. [2 ]
Shao, T. [1 ]
机构
[1] Tongde Hosp Zhejiang Prov, Infect Dis Dept, Hangzhou 310012, Peoples R China
[2] Tongde Hosp Zhejiang Prov, Dept Orthoped, Hangzhou 310012, Peoples R China
关键词
TO-BONE TEST; F-18-FDG PET; MANAGEMENT; MRI; SCINTIGRAPHY;
D O I
10.1016/j.crad.2024.05.015
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: This meta-analysis aimed to evaluate the comparative diagnostic efficacy of [18F]Flu- orodeoxyglucose positron emission tomography ([18F]FDG PET) and conventional imaging, MRI, and white blood cell (WBC) scintigraphy in detecting foot osteomyelitis among diabetic patients. MATERIALS AND METHODS: An exhaustive search was conducted within the PubMed and Embase databases to identify publications available up until February 2024. Studies were included if they evaluated the diagnostic efficacy of [18F]FDG PET or the comparative diagnostic performance between PET and (MRI or WBC scintigraphy). Two researchers independently assessed the quality of the included studies, utilizing the Quality Assessment of Diagnostic Performance Studies (QUADAS-2) tool. RESULTS: Nine retrospective or prospective studies involving 605 patients were included in the meta-analysis. For [18F]FDG PET, the overall sensitivity was 0.83(95% CI: 0.69-0.94), while the overall specificity was 0.92(95% CI: 0.86-0.97). In the head-to-head comparison, no significant difference of sensitivity was found between [18F]FDG PET and MRI (0.72 vs. 0.68, P=0.81), as well as between [18F]FDG PET and WBC scintigraphy (0.57 vs. 0.66, P=0.64). In addition, specificity was also found to be no significant difference between [18F]FDG PET and MRI (0.90 vs. 0.82, P=0.27), as well as [18F]FDG PET and WBC scintigraphy (0.81 vs. 0.93, P=0.09). CONCLUSION: [18F]FDG PET demonstrates similar sensitivity and specificity to MRI and WBC scintigraphy in detecting foot osteomyelitis among diabetic patients. MRI, often cited as a primary choice in guidelines, might be preferred due to its lower cost and lower dose. Further larger sample prospective studies are needed to confirm these findings. (c) 2024 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:e1142 / e1151
页数:10
相关论文
共 50 条
  • [21] Standardization of Scanning for [18F] Fluorodeoxyglucose Positron Emission Tomography IN REPLY
    Tanvetyanon, Tawee
    Eikman, Edward A.
    Bepler, Gerold
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 832 - 832
  • [22] [18F]Fluorodeoxyglucose positron emission tomography in advanced thyroid cancer
    Taieb, D.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2011, 35 (05): : 329 - 331
  • [23] [18F]-fluorodeoxyglucose positron emission tomography in an animal model of mania
    Hougland, Matthew Tyler
    Gao, YongLin
    Herman, Laura
    Ng, Chin K.
    Lei, Zhenmin
    El-Mallakh, Rif S.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 65S - 65S
  • [24] The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma
    Wudel, LJ
    Delbeke, D
    Morris, D
    Rice, M
    Washington, MK
    Shyr, Y
    Pinson, CW
    Chapman, WC
    AMERICAN SURGEON, 2003, 69 (02) : 117 - 124
  • [25] [18F] fluorodeoxyglucose positron-emission tomography-CT imaging of carotidynia
    Amaravadi, R. R.
    Behr, S. C.
    Kousoubris, P. D.
    Raja, S.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) : 1197 - 1199
  • [26] Fluorine-18-radiolabeled pharmaceuticals for imaging with positron emission tomography, excluding [18F]-fluorodeoxyglucose
    Pauwels, EKJ
    van der Klaauw, AA
    Corporaal, T
    Stokkel, MPM
    DRUGS OF THE FUTURE, 2002, 27 (07) : 655 - 667
  • [27] [18F]Fluorodeoxyglucose-positron emission tomography screening for lung cancer: a systematic review and meta-analysis
    Chien, Chun-Ru
    Liang, Ji-An
    Chen, Jin-Hua
    Wang, Hsiao-Nin
    Lin, Cheng-Chieh
    Chen, Chih-Yi
    Wang, Pin-Hui
    Kao, Chia-Hung
    Yeh, Jun-Jun
    CANCER IMAGING, 2013, 13 (04): : 458 - 465
  • [28] [18F]Difluorocarbene for positron emission tomography
    Sap, Jeroen B. I.
    Meyer, Claudio F.
    Ford, Joseph
    Straathof, Natan J. W.
    Durr, Alexander B.
    Lelos, Mariah J.
    Paisey, Stephen J.
    Mollner, Tim A.
    Hell, Sandrine M.
    Trabanco, Andres A.
    Genicot, Christophe
    Am Ende, Christopher W.
    Paton, Robert S.
    Tredwell, Matthew
    Gouverneur, Veronique
    NATURE, 2022, 606 (7912) : 102 - +
  • [29] [18F]Difluorocarbene for positron emission tomography
    Sap, Jeroen
    Gouverneur, Veronique
    Meyer, Claudio
    Ford, Joseph
    Straathof, Natan
    Durr, Alexander
    Lelos, Mariah
    Paisey, Stephen
    Mollner, Tim
    Hell, Sandrine
    Trabanco, Andres
    amEnde, Christopher
    Paton, Robert
    Tredwell, Matthew
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S69 - S70
  • [30] [18F]Difluorocarbene for positron emission tomography
    Jeroen B. I. Sap
    Claudio F. Meyer
    Joseph Ford
    Natan J. W. Straathof
    Alexander B. Dürr
    Mariah J. Lelos
    Stephen J. Paisey
    Tim A. Mollner
    Sandrine M. Hell
    Andrés A. Trabanco
    Christophe Genicot
    Christopher W. am Ende
    Robert S. Paton
    Matthew Tredwell
    Véronique Gouverneur
    Nature, 2022, 606 : 102 - 108